Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cidara Therapeutics, Inc. - Common Stock (NQ:CDTX)

44.95 +23.93 (+113.84%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,587,751
Open 40.63
Bid (Size) 44.69 (1)
Ask (Size) 44.90 (2)
Prev. Close 21.02
Today's Range 37.76 - 45.39
52wk Range 10.14 - 28.42
Shares Outstanding 49,506,268
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's session
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Cidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage Trial
Single doses of 450mg, 300mg, and 150mg of CD388 conferred 76%, 61%, and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo, the company said. 
Via Stocktwits

Performance

YTD
+64.7%
+64.7%
1 Month
+85.1%
+85.1%
3 Month
+90.2%
+90.2%
6 Month
+92.1%
+92.1%
1 Year
+298.1%
+298.1%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Falls 1%; US Services PMI Declines In June
Via Benzinga
Exposures Fossil Fuels
Earnings Scheduled For May 8, 2025
Via Benzinga
Which stocks are experiencing notable movement on Monday?
Via Chartmill
Cidara Launches 93% As A Universal Flu Shot Becomes A Closer Reality
Via Investor's Business Daily
Exposures Product Safety
Why Is Cidara Therapeutics Stock Trading Higher On Monday?
Via Benzinga
Exposures Product Safety
Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
These stocks are gapping in today's session
Via Chartmill
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
From Phathom Pharmaceuticals
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Cidara Therapeutics' Unique Cloudbreak Platform And Its Promise In Influenza And Oncology
Via Talk Markets
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
CDTX INVESTOR NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
CDTX INVESTOR NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
CDTX Stock Earnings: Cidara Therapeutics Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
CDTX INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – CDTX
From The Rosen Law Firm PA
Via GlobeNewswire
CDTX LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
CDTX LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is Cidara Therapeutics, Inc. - Common Stock publicly traded?
Yes, Cidara Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Cidara Therapeutics, Inc. - Common Stock trade on?
Cidara Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cidara Therapeutics, Inc. - Common Stock?
The ticker symbol for Cidara Therapeutics, Inc. - Common Stock is CDTX on the Nasdaq Stock Market
What is the current price of Cidara Therapeutics, Inc. - Common Stock?
The current price of Cidara Therapeutics, Inc. - Common Stock is 44.95
When was Cidara Therapeutics, Inc. - Common Stock last traded?
The last trade of Cidara Therapeutics, Inc. - Common Stock was at 06/23/25 04:00 PM ET
What is the market capitalization of Cidara Therapeutics, Inc. - Common Stock?
The market capitalization of Cidara Therapeutics, Inc. - Common Stock is 2.23B
How many shares of Cidara Therapeutics, Inc. - Common Stock are outstanding?
Cidara Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.